Recursion Pharmaceuticals
RXRX
NASDAQ
IPO2021
about RXRX
Recursion Pharmaceuticals specializes in leveraging AI and automation for drug discovery and development to create precision medicines.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $3.91 | $4.08 | $3.75 | $1.8B | 44.55M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.36 | n/a | 323.90 | -3327.57% | -3135.32% | 0% |